Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases
JC Hall, L Casciola-Rosen, AE Berger… - Proceedings of the …, 2012 - National Acad Sciences
Elucidating the molecular pathways active in pathologic tissues has important implications
for defining disease subsets, selecting therapy, and monitoring disease activity. The …
for defining disease subsets, selecting therapy, and monitoring disease activity. The …
[PDF][PDF] Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases
JC Halla, L Casciola-Rosena, AE Bergerb… - PNAS, 2012 - academia.edu
Results Genes Most Strongly Induced by IFN-α Are also Induced by IFN-γ. To define the
origin of the IFN signature in minor salivary gland biopsies from patients with SS, microarray …
origin of the IFN signature in minor salivary gland biopsies from patients with SS, microarray …
Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases
JC Hall, L Casciola-Rosen, AE Berger… - Proceedings of the …, 2012 - JSTOR
Elucidating the molecular pathways active in pathologic tissues has important implications
for defining disease subsets, selecting therapy, and monitoring disease activity. The …
for defining disease subsets, selecting therapy, and monitoring disease activity. The …
[PDF][PDF] Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases
JC Halla, L Casciola-Rosena, AE Bergerb… - PNAS, 2012 - researchgate.net
Results Genes Most Strongly Induced by IFN-α Are also Induced by IFN-γ. To define the
origin of the IFN signature in minor salivary gland biopsies from patients with SS, microarray …
origin of the IFN signature in minor salivary gland biopsies from patients with SS, microarray …
Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases
JC Hall, L Casciola-Rosen, AE Berger… - Proceedings of the …, 2012 - cir.nii.ac.jp
抄録< jats: p> Elucidating the molecular pathways active in pathologic tissues has important
implications for defining disease subsets, selecting therapy, and monitoring disease activity …
implications for defining disease subsets, selecting therapy, and monitoring disease activity …
Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases
JC Hall, L Casciola-Rosen, AE Berger… - Proceedings of the …, 2012 - pure.johnshopkins.edu
Elucidating the molecular pathways active in pathologic tissues has important implications
for defining disease subsets, selecting therapy, and monitoring disease activity. The …
for defining disease subsets, selecting therapy, and monitoring disease activity. The …
[HTML][HTML] Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases
JC Hall, L Casciola-Rosen, AE Berger… - Proceedings of the …, 2012 - ncbi.nlm.nih.gov
Elucidating the molecular pathways active in pathologic tissues has important implications
for defining disease subsets, selecting therapy, and monitoring disease activity. The …
for defining disease subsets, selecting therapy, and monitoring disease activity. The …
Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases.
JC Hall, L Casciola-Rosen, AE Berger… - Proceedings of the …, 2012 - europepmc.org
Elucidating the molecular pathways active in pathologic tissues has important implications
for defining disease subsets, selecting therapy, and monitoring disease activity. The …
for defining disease subsets, selecting therapy, and monitoring disease activity. The …
Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases
JC Hall, L Casciola-Rosen, AE Berger… - Proceedings of the …, 2012 - ui.adsabs.harvard.edu
Elucidating the molecular pathways active in pathologic tissues has important implications
for defining disease subsets, selecting therapy, and monitoring disease activity. The …
for defining disease subsets, selecting therapy, and monitoring disease activity. The …
Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases
JC Hall, L Casciola-Rosen… - Proceedings of the …, 2012 - pubmed.ncbi.nlm.nih.gov
Elucidating the molecular pathways active in pathologic tissues has important implications
for defining disease subsets, selecting therapy, and monitoring disease activity. The …
for defining disease subsets, selecting therapy, and monitoring disease activity. The …